Key Services

We are committed to launching products that make a difference in people’s lives. We work across a product’s lifecycle, supporting biotech, pharmaceutical, and medical technology companies across the globe.

Outcomes Research

Our team provide unequalled accuracy and quality whilst delivering all aspects of systematic reviews, meta-analyses and patient-level data analyses.

Economic Modelling

We develop a range of robust health economic models that meet the commercial needs of our clients from simple Markov models to complex discrete event simulations.

Health Technology Assessment

We have extensive experience delivering successful HTA submissions in the UK and across the globe.

Value Communication

We effectively communicate the value of your products in a logical and insightful manner; from internal value dossiers to external scientific publications.

Pricing & Reimbursement

We partner with our clients to develop strategies for global pricing and reimbursement, harnessing our extensive KOL and payer network.


Our white paper 'Is European market access becoming an incubator for rare disease development?' explores the hypothesis that successful commercialisation in Europe is the biggest commercial opportunity for orphan drug manufacturers right now.  Find out more about how you can navigate European changes with the support of a trusted vendor to achieve maximum global profit by downloading the white paper.


Patient advocacy is now the key to a successful product launch. Establishing relationships between patient advocacy groups and the pharmaceutical industry will ensure objective measures of efficacy are realised, and improved patient outcomes are achieved.

FIECON has launched a series of podcasts, talking to patients and patient advocacy leaders about the burden, unmet needs, patient journey and possible future treatment options to better understand the patient perspective.

Our hope is that a more comprehensive understanding of that patient perspective will help to optimise drug development, expenditures, and care into the future.

Patient Perspectives podcasts



We have delivered over 50 global HTA submissions in the last three years, with a success rate exceeding 90% across all indications, 100% in orphan conditions! We have a wealth of experience and knowledge that we utilize to navigate the requirements and nuances of HTA processes to ensure market access and a commercially acceptable price.


We were delighted to be recognised for our outstanding contribution to workplace philanthropy and presented with the Platinum Award for our Payroll Giving efforts in 2021/22, by the Charities Trust.

Payroll Giving is one of the most effective ways to give. It offers a simple way for our team members to donate to the good causes they are passionate about, tax free, direct from their pay and provides a regular income for the charities they support.

We support and encourage our people to give back to causes close to their hearts by matching Payroll Giving donations too.


FIECON Model Builder is an online platform which automates the design and building-process of Excel-based cost-effectiveness models.  High quality Excel models can be built in a matter of minutes rather than weeks. Models are set up with complete functionality, flexibility, and transparency. But most importantly our automated process removes the risk of human error and guarantees accuracy. Give yourself the best chance of success; save time and money with the right cost-effectiveness model from FIECON Model Builder.
Get in touch with our Head of Business Development, Karl Freemyer -, to book a demo or find out more.


FIECON Value Platform can help you manage and optimise your product’s pricing and market access processes. Your online portal helps Global teams quickly understand progress, priorities, and support needs in local markets, saving you time, increasing team efficiency, and ensuring unity and alignment. Save time, increase efficiency and ensure unity and alignment to give your products the best chance of achieving successful pricing and market access.
Get in touch with our Pricing and Market Access Director, Martin Schuchardt, to book a demo or find out more.